Assistant Professor
Badr University in Assiut, Egypt
Dr. Abdelrahman M. Helmy, an Assistant Professor at Badr University Assiut's Department of Pharmaceutics, is a distinguished expert in drug delivery and formulation science. His career is marked by a unique blend of academic and industrial expertise, providing him with a holistic understanding of pharmaceutical development from concept to market.
As a former U.S. Fulbright Postdoctoral Fellow at the University of Texas at Austin, Dr. Helmy led groundbreaking research in the 3D printing of numerous drug delivery systems and Amorphous Solid Dispersions. This effort resulted in a filed U.S. patent and multiple first/second-author publications. His interdisciplinary background includes a master's focus on particle engineering for enhanced manufacturability and bioavailability, and a Ph.D. in colon-targeted drug delivery for boosted therapeutic efficiency. His translational research work spans a diverse portfolio, including the development of 3D-printed conductive polymer wearables for transdermal delivery and nanotechnology for targeted therapies in cancer and the brain. He has also developed biomaterial-based platforms such as ocular nanofibers, controlled-release in-situ gels, dermal hydrogels, and nasal films.
Before his academic career, Dr. Helmy spent nine years in the pharmaceutical industry as a pharmaceutical researcher and analytical chemist. This hands-on experience provides him with invaluable knowledge in comprehensive formulation development and process optimization for a diverse portfolio of dosage forms. He is proficient in a wide range of analytical methodologies and is well-versed in GMP regulations. During his industrial career, he successfully led a shift to a greener industry, reducing costs and enhancing efficiency, which instilled in him a strong commitment to sustainability.
Dr. Helmy is passionate about knowledge transfer and mentorship and is motivated by a commitment to societal well-being, focusing on the development of affordable healthcare solutions. He embodies the ideal of a visionary researcher and a practical innovator, ready to tackle the complex challenges of modern pharmaceutical science.